About 1 result found for searched term "Bimekizumab" (0.176 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M24662 | Bimekizumab | IL Receptor/Related |
| Anti-Human IL17A/IL-17F Recombinant Antibody | ||
| Bimekizumab (Anti-Human IL17A/IL-17F Recombinant Antibody) is a humanised monoclonal antibody, can selectively neutralises IL-17A and IL-17F. Both of them are pro-osteogenic with respect to human periosteum-derived cell (hPDC) differentiation. Thus Bimekizumab blocks the inflammation-driven osteogenic differentiation. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
